95-4242. National Cancer Institute; Meetings  

  • [Federal Register Volume 60, Number 35 (Wednesday, February 22, 1995)]
    [Notices]
    [Pages 9852-9853]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 95-4242]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    National Institute of Health
    
    
    National Cancer Institute; Meetings
    
        Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
    Cancer Institute (NCI) advisory committee meetings.
        These meetings will be open to the public as indicated below with 
    attendance limited to space available. Individuals who plan to attend 
    and need special assistance, such as sign language interpretation or 
    other reasonable accommodations, should notify the contact person in 
    advance of the meeting.
        Ms. Carole Frank, NCI Committee Management Officer, National 
    Institutes of Health, Executive Plaza North, Room 630E, 6130 Executive 
    Boulevard MSC 7405, Bethesda, Maryland 20892-7405, (301) 496-5708, will 
    provide summaries of the meetings and rosters of committee members upon 
    request. Substantive program information may be obtained from the 
    contacts listed below.
    
    Committee Name: Developmental Therapeutics Contracts Review Committee.
    Contact Person: Dr. C. Michael Kerwin, Scientific Review Administrator, 
    DEA, NCI, NIH, Executive Plaza North, Room 601A, 6130 Executive 
    Boulevard, Rockville, MD 20852-7405, Telephone: (301) 496-7421
    Date of Meeting: March 3, 1995
    Place of Meeting: Executive Plaza North, Conference Room J, 6130 
    Executive Boulevard, Rockville, MD 20852
    Closed: 9 am to adjournment
    Agenda: Review, discussion and evaluation of individual contract 
    proposals.
    
    Committee Name: Board of Scientific Counselors, Division of Cancer 
    Biology, Diagnosis, and Centers
    Contact person: Dr. Ihor J. Masnyk, Executive Secretary, NCI, NIH, 
    Building 31A, Room 3A11, 9000 Rockville Pike, Bethesda, MD 20892-2440, 
    Telephone: (301) 496-3251
    Date of Meeting: March 6, 1995
    Place of Meeting: Building 31C--Conference Room 10, National Institutes 
    of Health, 9000 Rockville Pike, Rockville, MD 20892
    Open: 8:30 am to adjournment
    Agenda: Discussion and review of the division budget and review of 
    concepts for grants and contracts.
    
        These meetings will be closed, as indicated, in accordance with 
    provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, 
    U.S.C. Proposals and the discussions could reveal confidential trade 
    secrets or commercial property such as patentable material and personal 
    information concerning individuals associated with the proposals, 
    disclosure of which would constitute a clearly unwarranted invasion of 
    personal privacy.
        This notice is being published less than fifteen days prior to the 
    meeting due to the urgent need to meet timing limitations imposed by 
    the review cycle.
    
    (Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
    Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
    Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
    Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
    Cancer Research Manpower; 93.399, Cancer Control)
    
        [[Page 9853]] Dated: February 15, 1995.
    Susan K. Feldman,
    Committee Management Officer, National Institutes of Health.
    [FR Doc. 95-4242 Filed 2-21-95; 8:45 am]
    BILLING CODE 4140-01-M
    
    

Document Information

Published:
02/22/1995
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
95-4242
Pages:
9852-9853 (2 pages)
PDF File:
95-4242.pdf